New
HealthMore in Health→
Semaglutide study links diabetes treatment to lower fracture risk
Key Takeaways
- ENDO 2026 researchers reported a 15% lower fracture rate with semaglutide.
- The study compared semaglutide with dulaglutide and two oral weight-loss therapies.
- The analysis used U.S. electronic health records from 2016 through 2023.
- Authors say prospective studies are still needed.
DE
DT Editorial Team··via medicalxpress.com